Review Board Recommends Bayer Halt Disparaging Glucose Monitor Ads
This article was originally published in The Gray Sheet
Executive Summary
The National Advertising Review Board (NARB) recommends that Bayer stop claiming that its competitors' manually calibrated glucose meters are prone to inaccuracy and possibly dangerous